Cardiovascular Systems Inc.

15.09-0.6500-4.13%Vol 289.37K1Y Perf -58.16%
May 18th, 2022 16:00 DELAYED
BID10.15 ASK21.00
Open15.39 Previous Close15.74
Pre-Market- After-Market15.09
 - -  - -%
Target Price
30.33 
Analyst Rating
Hold 2.67
Potential %
100.99 
Finscreener Ranking
★★★★     53.98
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★★★     56.91
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★     46.14
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
3.19 
Earnings Rating
Strong Sell
Market Cap615.45M 
Earnings Date
4th May 2022
Alpha-0.01 Standard Deviation0.13
Beta0.91 

Today's Price Range

14.9515.73

52W Range

14.1244.57

5 Year PE Ratio Range

-1 300.00912.30

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
6.86%
1 Month
-24.69%
3 Months
-16.37%
6 Months
-34.96%
1 Year
-58.16%
3 Years
-60.19%
5 Years
-49.98%
10 Years
68.88%

TickerPriceChg.Chg.%
CSII15.09-0.6500-4.13
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Financial StrengthValueIndustryS&P 500US Markets
4.50
5.30
0.07
0.08
-18.60
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
72.30
-12.50
-10.40
-3.30
-13.46
RevenueValueIndustryS&P 500US Markets
244.71M
6.00
0.83
4.29
Earnings HistoryEstimateReportedSurprise %
Q03 2022-0.28-0.2510.71
Q02 2022-0.14-0.23-64.29
Q01 2022-0.10-0.22-120.00
Q04 2021-0.17-0.1417.65
Q03 2021-0.10-0.15-50.00
Q02 2021-0.070.00100.00
Q01 2021-0.23-0.0578.26
Q04 2020-0.44-0.432.27
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.2215.38Positive
6/2022 FY-0.917.14Positive
9/2022 QR-0.23-53.33Negative
6/2023 FY-0.76-65.22Negative
Next Report Date-
Estimated EPS Next Report-0.28
Estimates Count6
EPS Growth Next 5 Years %8.10
Volume Overview
Volume289.37K
Shares Outstanding40.79K
Shares Float26.44M
Trades Count5.91K
Dollar Volume4.39M
Avg. Volume370.29K
Avg. Weekly Volume424.76K
Avg. Monthly Volume357.06K
Avg. Quarterly Volume329.04K

Cardiovascular Systems Inc. (NASDAQ: CSII) stock closed at 15.74 per share at the end of the most recent trading day (a 3.21% change compared to the prior day closing price) with a volume of 621.04K shares and market capitalization of 615.45M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 779 people. Cardiovascular Systems Inc. CEO is Scott R. Ward.

The one-year performance of Cardiovascular Systems Inc. stock is -58.16%, while year-to-date (YTD) performance is -16.19%. CSII stock has a five-year performance of -49.98%. Its 52-week range is between 14.12 and 44.57, which gives CSII stock a 52-week price range ratio of 3.19%

Cardiovascular Systems Inc. currently has a PE ratio of -19.00, a price-to-book (PB) ratio of 2.56, a price-to-sale (PS) ratio of 2.54, a price to cashflow ratio of 289.80, a PEG ratio of 2.32, a ROA of -9.98%, a ROC of -11.31% and a ROE of -12.78%. The company’s profit margin is -13.46%, its EBITDA margin is -10.40%, and its revenue ttm is $244.71 Million , which makes it $6.00 revenue per share.

Of the last four earnings reports from Cardiovascular Systems Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.28 for the next earnings report. Cardiovascular Systems Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Cardiovascular Systems Inc. is Hold (2.67), with a target price of $30.33, which is +100.99% compared to the current price. The earnings rating for Cardiovascular Systems Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cardiovascular Systems Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cardiovascular Systems Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 9.67, ATR14 : 1.17, CCI20 : -62.82, Chaikin Money Flow : -0.08, MACD : -1.56, Money Flow Index : 50.47, ROC : -15.83, RSI : 37.74, STOCH (14,3) : 25.12, STOCH RSI : 1.00, UO : 44.79, Williams %R : -74.88), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cardiovascular Systems Inc. in the last 12-months were: Erik Paulsen (Buy at a value of $9 523), Jeffrey S. Points (Buy at a value of $36 400), Martha Goldberg Aronson (Buy at a value of $46 075), Rhonda J. Robb (Buy at a value of $29 326), Scott R. Ward (Buy at a value of $46 293)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (22.22 %)
2 (22.22 %)
3 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
6 (66.67 %)
6 (66.67 %)
6 (66.67 %)
Moderate Sell
1 (11.11 %)
1 (11.11 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
2.67
Hold
2.67
Moderate Buy
2.33

Cardiovascular Systems Inc.

Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generates the vast majority of its revenue in the United States.

CEO: Scott R. Ward

Telephone: +1 651 259-1600

Address: 1225 Old Highway 8 Northwest, St. Paul 55112-6416, MN, US

Number of employees: 779

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

61%39%

Bearish Bullish

56%44%

TipRanks News for CSII

Wed, 18 May 2022 09:25 GMT Cardiovascular Systems (CSII) Gets a Hold Rating from Needham

- TipRanks. All rights reserved.

Thu, 05 May 2022 12:46 GMT Cardiovascular Systems (CSII) Gets a Buy Rating from SVB Securities

- TipRanks. All rights reserved.

Wed, 13 Apr 2022 09:45 GMT Analysts Offer Insights on Healthcare Companies: Cardiovascular Systems (CSII) and Evofem Biosciences (EVFM)

- TipRanks. All rights reserved.

Sun, 06 Feb 2022 13:38 GMT Cardiovascular Systems (CSII) Gets a Buy Rating from Leerink Partners

- TipRanks. All rights reserved.

News

Stocktwits